Vanderbilt
EHR-Based Model Predicts Patients Who May Benefit from Genetic Testing for Rare Disease
Researchers from Vanderbilt University Medical Center said their approach could systematize who undergoes testing and shorten diagnostic odysseys.
The talks focused on studies stemming from the Cancer Moonshot initiative's Human Tumor Atlas Network project, which is readying its first data release.
Syntegra Teams With Vanderbilt's Nashville Biosciences on Biobank Data Analysis for Drug R&D
Data analysis firm Syntegra will work with NashBio to produce and validate synthetic data from the BioVU biobank, starting with type 2 diabetes.
Appendiceal Cancer Sequences Suggest Distinct Mutation Patterns in Early-, Late-Onset Cases
With clinical sequencing data for almost 400 appendiceal cancer cases, researchers identified somatic differences in individuals diagnosed with the disease before the age of 50.
The firm is also pursuing advances in its manufacturing and ordering processes that it says will help it scale to $500 million in annual revenues.